Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
NCT00439283Phase 3Completed
- Sponsor
- Association de Recherche Clinique en Rhumatologie
- Start
- Apr 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in ankylosing spondylitis (AS), sponsored by Association de Recherche Clinique en Rhumatologie. Started Apr 2003; status: completed.
02
Drugs
infliximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00439283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439283.